• BS, Biochemistry
  University of Maryland, College Park (2007)
  
• PhD Candidate, Molecular and Systems Pharmacology
  Emory University ()
  

Depression affects approximately 11% of pregnant women. Treatment is problematic due to balancing potential risk from antidepressant exposure in utero and the effects of maternal depression on the fetus. Therefore, my research will focus on the offspring and establish the risks of prenatal stress and benefits of treatment intervention during pregnancy. This study will establish the benefits of treating pregnant women diagnosed with major depressive disorder and whether antidepressant treatment would adversely affect the infant.